Straus, D., Collins, G., Walewski, J., Zinzani, P. L., Grigg, A., Sureda, A., Illes, A., Kim, T. M., Alekseev, S., Specht, L., Buccheri, V., Younes, A., Connors, J., Forero-Torres, A., Fenton, K., Gautam, A., Purevjal, I., Liu, R., & Gallamini, A. (2020). primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Leukemia & lymphoma, 61(12), 2931–2938. http://access.bl.uk/ark:/81055/vdc_100114890574.0x00002b